fbpx

The leading point-of-care wound imaging devices for the detection of the presence and location of elevated bacterial loads and for accurate digital wound measurement.

MolecuLight i:X 

 Wound Imaging Device

The MolecuLight i:X allows clinicians to quickly, safely and easily visualize bacteria and measure wounds at the point of care.

What does MolecuLight i:X do?

Visualise Bacteria

MolecuLight i:X allows clinicians to focus on potentially harmful levels of bacteria with the guidance of fluorescence imaging.

Measure Wound Area

MolecuLight i:X provides clinicians with a comprehensive toolkit for digital wound area measurement and documentation.

See What You’re Missing

  1. When explaining about how it works, I’ve a few suggestions below in red.

The MolecuLight i:X emits a precise wavelength of safe violet light, which interacts with the wound tissue and bacteria causing the wound and surrounding skin to emit a green fluorescence (i.e. collagen) and potentially harmful bacteria to emit a red fluorescence (i.e. porphyrins).1 Cyan fluorescence indicates the presence of Pseudomonas aeruginosa1In real-time, MolecuLight i:X captures these red, green and cyan fluorescence signals using specialized optical components to filter out the violet light, and displays the resultant image immediately on the display screen (FL-image).1,2 The MolecuLight i:X is precisely calibrated to detect fluorescent bacteria at levels of ≥ 104 CFU/g on a quantitative scale or predominantly moderate to heavy growth on a semi-quantitative scale.1 Knowledge about bacterial burden can help in all areas of wound care, promoting healing3 and antimicrobial stewardship4.

New peer-reviewed publications featuring MolecuLight appeared in:

References

1. Le L, Baer M, Briggs P, Bullock N, Cole W, DiMarco D, Hamil R, Harrell K, Kasper M, Li W, Patel K, Sabo M, Thibodeaux K, Serena TE. Diagnostic Accuracy of Point-of-Care Fluorescence Imaging for the Detection of Bacterial Burden in Wounds: Results from the 350-Patient Fluorescence Imaging Assessment and Guidance Trial. Adv Wound Care (New Rochelle). 2021 Mar;10(3):123-136.2. Rennie MY, Dunham D, Lindvere-Teene L, Raizman R, Hill R, Linden R. Understanding Real-Time Fluorescence Signals from Bacteria and Wound Tissues Observed with the MolecuLight i:XTM. Diagnostics (Basel). 2019 Feb 26;9(1):22.3. Rahma S, Woods J, Brown S, Nixon J, Russell D. The Use of Point-of-Care Bacterial Autofluorescence Imaging in the Management of Diabetic Foot Ulcers: A Pilot Randomized Controlled Trial. Diabetes Care. 2022 Jul 7;45(7):1601-1609.4. Price N. Routine Fluorescence Imaging to Detect Wound Bacteria Reduces Antibiotic Use and Antimicrobial Dressing Expenditure While Improving Healing Rates: Retrospective Analysis of 229 Foot Ulcers. Diagnostics (Basel). 2020 Nov 10;10(11):927.